Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Marston

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
The Journal of Biological Chemistry|August 21, 2002
Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathyPaul Robinson, Mahmooda Mirza, Adam Knott, et al.
The Journal of Biological Chemistry|June 1, 2005
Dilated cardiomyopathy mutations in three thin filament regulatory proteins result in a common functional phenotypeMahmooda Mirza, Steven Marston, Ruth Willott, et al.
The Biochemical Journal|November 17, 2011
Abnormal actin binding of aberrant β-tropomyosins is a molecular cause of muscle weakness in TPM2-related nemaline and cap myopathyMinttu Marttila, Elina Lemola, William Wallefeld, et al.
Plos One|September 26, 2015
OBSCN Mutations Associated with Dilated Cardiomyopathy and HaploinsufficiencySteven Marston, Cecile Montgiraud, Alex B Munster, et al.
The Journal of Biological Chemistry|March 16, 2007
The effect of mutations in alpha-tropomyosin (E40K and E54K) that cause familial dilated cardiomyopathy on the regulatory mechanism of cardiac muscle thin filamentsMahmooda Mirza, Paul Robinson, Elena Kremneva, et al.
Human Molecular Genetics|July 27, 2013
Mutations in repeating structural motifs of tropomyosin cause gain of function in skeletal muscle myopathy patientsSteven Marston, Massimiliano Memo, Andrew Messer, et al.
Circulation Research|July 4, 2009
Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiencySteven Marston, O'Neal Copeland, Adam Jacques, et al.
Annals of Neurology|March 28, 2007
The pathogenesis of ACTA1-related congenital fiber type disproportionNigel F Clarke, Biljana Ilkovski, Sandra Cooper, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 23, 2013
Mechanical and energetic properties of papillary muscle from ACTC E99K transgenic mouse models of hypertrophic cardiomyopathyWeihua Song, Petr G Vikhorev, Mavin N Kashyap, et al.
Journal of Molecular and Cellular Cardiology|July 6, 2010
Investigation of a transgenic mouse model of familial dilated cardiomyopathyWeihua Song, Emma Dyer, Daniel Stuckey, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|August 21, 2002
Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathyPaul Robinson, Mahmooda Mirza, Adam Knott, et al.
The Journal of Biological Chemistry|June 1, 2005
Dilated cardiomyopathy mutations in three thin filament regulatory proteins result in a common functional phenotypeMahmooda Mirza, Steven Marston, Ruth Willott, et al.
The Biochemical Journal|November 17, 2011
Abnormal actin binding of aberrant β-tropomyosins is a molecular cause of muscle weakness in TPM2-related nemaline and cap myopathyMinttu Marttila, Elina Lemola, William Wallefeld, et al.
Plos One|September 26, 2015
OBSCN Mutations Associated with Dilated Cardiomyopathy and HaploinsufficiencySteven Marston, Cecile Montgiraud, Alex B Munster, et al.
The Journal of Biological Chemistry|March 16, 2007
The effect of mutations in alpha-tropomyosin (E40K and E54K) that cause familial dilated cardiomyopathy on the regulatory mechanism of cardiac muscle thin filamentsMahmooda Mirza, Paul Robinson, Elena Kremneva, et al.
Human Molecular Genetics|July 27, 2013
Mutations in repeating structural motifs of tropomyosin cause gain of function in skeletal muscle myopathy patientsSteven Marston, Massimiliano Memo, Andrew Messer, et al.
Circulation Research|July 4, 2009
Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiencySteven Marston, O'Neal Copeland, Adam Jacques, et al.
Annals of Neurology|March 28, 2007
The pathogenesis of ACTA1-related congenital fiber type disproportionNigel F Clarke, Biljana Ilkovski, Sandra Cooper, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 23, 2013
Mechanical and energetic properties of papillary muscle from ACTC E99K transgenic mouse models of hypertrophic cardiomyopathyWeihua Song, Petr G Vikhorev, Mavin N Kashyap, et al.
Journal of Molecular and Cellular Cardiology|July 6, 2010
Investigation of a transgenic mouse model of familial dilated cardiomyopathyWeihua Song, Emma Dyer, Daniel Stuckey, et al.
Pageof 4